Acura Pharmaceuticals Cash on Hand 2012-2021 | ACUR
Acura Pharmaceuticals cash on hand from 2012 to 2021. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
Acura Pharmaceuticals Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $1 |
| 2018 | $0 |
| 2017 | $2 |
| 2016 | $5 |
| 2015 | $13 |
| 2014 | $12 |
| 2013 | $26 |
| 2012 | $27 |
| 2011 | $36 |
|
Acura Pharmaceuticals Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | $0 |
| 2020-09-30 | $0 |
| 2020-06-30 | $1 |
| 2020-03-31 | $1 |
| 2019-12-31 | $1 |
| 2019-09-30 | $1 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $1 |
| 2018-03-31 | $1 |
| 2017-12-31 | $2 |
| 2017-09-30 | $5 |
| 2017-06-30 | $4 |
| 2017-03-31 | $6 |
| 2016-12-31 | $5 |
| 2016-09-30 | $4 |
| 2016-06-30 | $7 |
| 2016-03-31 | $11 |
| 2015-12-31 | $13 |
| 2015-09-30 | $15 |
| 2015-06-30 | $11 |
| 2015-03-31 | $14 |
| 2014-12-31 | $12 |
| 2014-09-30 | $15 |
| 2014-06-30 | $17 |
| 2014-03-31 | $22 |
| 2013-12-31 | $26 |
| 2013-09-30 | $19 |
| 2013-06-30 | $19 |
| 2013-03-31 | $23 |
| 2012-12-31 | $27 |
| 2012-09-30 | $29 |
| 2012-06-30 | $31 |
| 2012-03-31 | $33 |
| 2011-12-31 | $36 |
| 2011-09-30 | $38 |
| 2011-06-30 | $40 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.000B | $0.000B |
| Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |